4//SEC Filing
Dunsire Deborah 4
Accession 0000950170-24-075491
CIK 0001515673other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 2:29 PM ET
Size
6.8 KB
Accession
0000950170-24-075491
Insider Transaction Report
Form 4
Dunsire Deborah
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-18+9,900→ 9,900 totalExercise: $37.42Exp: 2034-06-18→ Common Stock (9,900 underlying) - Award
Common Stock
2024-06-18+5,345→ 25,075 total
Footnotes (2)
- [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025.
- [F2]The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025.
Documents
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeother
Related Parties
1- filerCIK 0001332764
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 2:29 PM ET
- Size
- 6.8 KB